Oncology & Cancer

Immune cell receptor provides promising immunotherapy target

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the ...

Oncology & Cancer

'Virtual biopsy' uses AI to help doctors assess lung cancer

Imperial researchers have used artificial intelligence (AI) to extract information about the chemical makeup of lung tumors from medical scans. For the first time, they have demonstrated how combining medical imaging with ...

Oncology & Cancer

TB vaccine shrinks liver cancer tumors in mice

A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumor burden and extended the survival of mice with liver cancer. The study, published ...

Oncology & Cancer

Researchers find links between human, canine brain tumors

Texas A&M School of Veterinary Medicine & Biomedical Sciences (VMBS), Baylor College of Medicine, and Texas Children's Hospital researchers have discovered that meningiomas—the most common type of brain tumor in humans ...

Oncology & Cancer

Outlining the future of theranostics in neurooncology

Nuclear medicine has the potential to change the landscape of theranostics in neurooncology, according to a new article published in The Journal of Nuclear Medicine (JNM). With recent advances in techniques to permeate the ...

Oncology & Cancer

Researchers characterize the immune landscape in cancer

Researchers have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field. The findings were published in the February 14 online issue of Cell in a paper titled "Pan-cancer ...

page 5 from 40